Concepedia

Results of a randomised phase II study comparing docetaxel with methotrexate in patients with recurrent head and neck cancer

Emmanuel Guardiola, Frédéric Peyrade, L. Chaigneau, Didier Cupissol, X. Tchiknavorian, Emmanuelle Bompas, A. Madroszyk, Philippe Ronchin, M. Schneider, J.P. Bleuze,

European Journal of Cancer · 2004 · 117 citations · 11 references

DOI

Concepts

References

11

Optimal two-stage designs for phase II clinical trials

Richard Simon · Controlled Clinical Trials · 1989 · 3.6K citations

, , +6

Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study.

Arlene A. Forastiere, Barbara Metch, Dorit Elisabeth Schuller et al. · Journal of Clinical Oncology · 1992 · 751 citations

Docetaxel (Taxotere®): An active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck

G. Catimel, Jaap Verweij, Vera Mattijssen et al. · Annals of Oncology · 1994 · 258 citations

, , +7

Phase I trial of docetaxel administered by weekly infusion in patients with advanced refractory cancer.

John D. Hainsworth, Howard A. Burris, Joan B. Erland et al. · Journal of Clinical Oncology · 1998 · 251 citations

Docetaxel: an active drug for squamous cell carcinoma of the head and neck.

Arnon I. Dreyfuss, J. Clark, Charles M. Norris et al. · Journal of Clinical Oncology · 1996 · 233 citations